임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
29건 표시
- 단계 미표기모집 예정· Breast Neoplasms탈젠나® 한국 시판 후 조사(PMS) 연구
Korea Post Marketing Surveillance (PMS) Study of Talzenna®
리드: 화이자
- 단계 미표기모집 예정· HER2-positive Locally Advanced Unresectable한국 시장 출시 후 투키사의 임상 유용성에 관한 연구
A Study to Learn More About Tukysa Once it is Out in the Korean Market
리드: 화이자
- 2/3상모집 예정· Plasmablastic LymphomaHEME-25: 신규 진단 형질모세포 림프종(HIV 동반 여부 무관)에서 엘라나타맙의 공개 가능성 평가 연구
HEME-25: Open-Label Feasibility Study of Elranatamab Utilized in Newly Diagnosed Plasmablastic Lymphoma With or Without HIV
협력: 화이자
- 단계 미표기모집 예정· Migraine With or Without AuraA Study to Learn About the Study Medicine NURTEC® ODT 75 mg After it is Released Into the Markets in Korea
리드: 화이자
- 단계 미표기모집 예정· Infectious DiseasesA Study to Learn About the Study Medicine - Zavicefta in Patients With Sepsis or Loss of Kidney Function in Japan
리드: 화이자
- 단계 미표기모집 예정· Cardiac AmyloidosisRetrospective Identification of Scintigraphic Cardiac Amyloidosis (RISCA)
협력: 화이자
- 2상모집 예정· Metastatic Castrate Resistant Prostate Cancer (mCRPC)A Study of Mevrometostat With Enzalutamide in People With Prostate Cancer Who Have Previously Received Androgen Receptor Pathway Inhibitor Therapy
협력: 화이자
- 단계 미표기모집 예정· Non-Small Cell Lung Cancer (NSCLC)Management Strategy of 1L Lorlatinib With Hyperlipidemia in Stage IIIB-IV ALK Positive NSCLC
협력: 화이자
- 2상모집 예정· Multiple Myeloma (MM)A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma
협력: 화이자
- 단계 미표기모집 예정· Respiratory Syncytial Virus InfectionsEvaluating the Benefits of RSV Maternal Vaccination Using a Scottish National Dataset
리드: 화이자
- 1상모집 예정· Non-small Cell Lung Cancer (NSCLC)A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Weight Loss
리드: 화이자
- 4상모집 예정· Acute Treatment of MigraineA Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India
리드: 화이자
- 해당없음모집 예정· HER2+ Metastatic Breast Cancer (MBC)Patient Navigation for HER2+ Metastatic Breast Cancer Patients Treated With Tucatinib
협력: 화이자
- 3상모집 예정· Respiratory Syncytial Virus (RSV)A Phase 3 Study in India to Describe the Safety and Immunogenicity of RSVpreF
리드: 화이자
- 단계 미표기모집 예정· Respiratory Syncytial Virus (RSV)Real-World Effectiveness of RSV Vaccines Among Adults Using Target Trial Emulation in Epic Cosmos
리드: 화이자
- 1/2상모집 예정· B-cell Acute Lymphoblastic LeukemiaA Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia
협력: 암젠, 화이자
- 2상모집 예정· Metastatic (Stage IV) MelanomaClinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.
협력: 화이자
- 단계 미표기모집 예정· Chronic DiseaseIntegrating Vaccination Into Hospital Care Pathways for Vulnerable Patients
협력: 화이자
- 단계 미표기모집 예정· TCE-RRMMASPIRE: A Registry Study Of Chinese Patients With TCE-RRMM Treated By Elranatamab
협력: 화이자
- 단계 미표기모집 예정· Coronavirus Disease 2019 (COVID-19)A Study to Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults Aged 60 and Older Living in Korean Long-term Care Hospitals Who Have COVID-19
리드: 화이자
- 해당없음모집 예정· Metastatic Breast CancerCollaborative cOMMUNIty Care for Metastatic breAsT cancEr Patients in inDonesia (Communicated)
협력: 화이자
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.